Wuhan Keqian Biology Co.,Ltd (688526.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Wuhan Keqian Biology Co.,Ltd
Sector
Healthcare
Industry
Biotechnology
Employees
923
First IPO Date
September 22, 2020
Key Executives
| Name | Title | Pay | Year Born |
| Ming Zhong | Chief Financial Officer, Deputy GM & Vice Chairman | 0 | 1983 |
| Mulin Chen | GM & Chairman | 0 | 1988 |
| Deng Hong | Deputy General Manager | 0 | 1984 |
| Guanping Chen | Deputy General Manager | 0 | 1967 |
| Xibiao Tang | Deputy General Manager | 0 | 1980 |
| Gaoyuan Xu | Executive Deputy General Manager | 0 | 1976 |
| Tiantian Zou | Board Secretary | 0 | 1983 |
| Chan Cha Chen | Accounting Supervisor | 0 | N/A |
AD
Description
Established in 2001 and headquartered in Wuhan, China, Wuhan Keqian Biology Co.,Ltd specializes in the comprehensive lifecycle of veterinary biological products across the Chinese market. The company's operations encompass innovative research and development, manufacturing, distribution, and delivering essential technical services aimed at controlling animal epidemics. Their product portfolio features a diverse array of vaccines for livestock, including swine and poultry, alongside companion animals, as well as various diagnostic tools.
AD
